IGF1 and histiocytic sarcoma: Definitive diagnosis of HS is based on elevated GH and/or IGF-1 concentrations followed by advanced diagnostic imaging modalities, i.e., computed tomography (CT) or magnetic-resonance imaging, with the detection of an enlargement of the pituitary gland [12,13].